CG
LRMR icon

Cutler Group’s Larimar Therapeutics LRMR Stock Holding History

Cutler Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-400
Closed -$3.12K – 3033
2023
Q4 		$1K Hold
400
– – ﹤0.01% 3359
2023
Q3 		$1K Sell
400
-400
-50% -$1.51K ﹤0.01% 3560
2023
Q2 		$2K Hold
800
– – ﹤0.01% 3049
2023
Q1 		$3K Sell
800
-200
-20% -$1.04K ﹤0.01% 2983
2022
Q4 		$4K Hold
1,000
– – ﹤0.01% 3321
2022
Q3 		$3K Sell
1,000
-200
-17% -$501 ﹤0.01% 3980
2022
Q2 		$2K Hold
1,200
– – ﹤0.01% 4307
2022
Q1 		$4K Hold
1,200
– – ﹤0.01% 4293
2021
Q4 		$12K Buy
+1,200
New +$13.3K ﹤0.01% 3548
2019
Q1 		– Sell
-8
Closed – – 4442
2018
Q4 		$0 Sell
8
-9
-53% -$888 ﹤0.01% 4315
2018
Q3 		$2K Buy
17
+9
+113% +$1.09K ﹤0.01% 3524
2018
Q2 		$1K Hold
8
– – ﹤0.01% 3867
2018
Q1 		$0 Hold
8
– – ﹤0.01% 4890
2017
Q4 		$0 Hold
8
– – ﹤0.01% 5464
2017
Q3 		$0 Hold
8
– – ﹤0.01% 6324
2017
Q2 		$0 Hold
8
– – ﹤0.01% 6747
2017
Q1 		$0 Sell
8
-390
-98% -$19.4K ﹤0.01% 6842
2016
Q4 		$15K Buy
398
+15
+4% +$608 ﹤0.01% 3756
2016
Q3 		$15K Buy
383
+266
+227% +$12.1K ﹤0.01% 3723
2016
Q2 		$8K Sell
117
-217
-65% -$17.2K ﹤0.01% 4430
2016
Q1 		$26K Sell
334
-118
-26% -$9.31K ﹤0.01% 3005
2015
Q4 		$34K Buy
+452
New +$72.6K ﹤0.01% 2865

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cutler Group's LRMR Position: Q1 2024 in Review

Cutler Group sold out of Larimar Therapeutics (LRMR) in Q1 2024, closing a stake of 400 shares — an estimated $3.12K sold.

Cutler Group first reported a position in LRMR in Q4 2015 and held it in 22 quarters. The position peaked at $34K in Q4 2015. 104 funds tracked by Wall St. Rank hold LRMR as of Q1 2024.

  • Cutler Group reported no remaining Larimar Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 400 Larimar Therapeutics shares in Q1 2024, an estimated $3.12K.
  • Cutler Group first reported a position in Larimar Therapeutics in Q4 2015 and held it in 22 quarters.
  • Cutler Group's Larimar Therapeutics position peaked at $34K in Q4 2015.
  • 104 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.